Long-term effects of resveratrol supplementation on suppression of atherogenic lesion formation and cholesterol synthesis in apo E-deficient mice.
about
Resveratrol and clinical trials: the crossroad from in vitro studies to human evidencePhytochemical Compounds and Protection from Cardiovascular Diseases: A State of the ArtAn Organ System Approach to Explore the Antioxidative, Anti-Inflammatory, and Cytoprotective Actions of ResveratrolPON1 and Mediterranean DietResveratrol-Induced Vascular Progenitor Differentiation towards Endothelial Lineage via MiR-21/Akt/β-Catenin Is Protective in Vessel Graft ModelsActivation of SIRT1 by resveratrol induces KLF2 expression conferring an endothelial vasoprotective phenotype.Sudachitin, a polymethoxylated flavone, improves glucose and lipid metabolism by increasing mitochondrial biogenesis in skeletal muscle.Resveratrol, a red wine constituent, blocks the antimitogenic effects of estradiol on human female coronary artery smooth muscle cells.Epigenetic drugs against cancer: an evolving landscape.A pilot randomized, placebo controlled, double blind phase I trial of the novel SIRT1 activator SRT2104 in elderly volunteers.Resveratrol prevents high fat/sucrose diet-induced central arterial wall inflammation and stiffening in nonhuman primates.Resveratrol plays dual roles in pancreatic cancer cells.Atherosclerosis and Alzheimer--diseases with a common cause? Inflammation, oxysterols, vasculatureUrsolic acid protects diabetic mice against monocyte dysfunction and accelerated atherosclerosis.Ethanolic Extract of Vitis thunbergii Exhibits Lipid Lowering Properties via Modulation of the AMPK-ACC Pathway in Hypercholesterolemic Rabbits.Resveratrol: French paradox revisited.Resveratrol, wine, and atherosclerosis.Anti-inflammatory properties of sirtuin 6 in human umbilical vein endothelial cellsResveratrol protects against diet-induced atherosclerosis by reducing low-density lipoprotein cholesterol and inhibiting inflammation in apolipoprotein E-deficient mice.Resveratrol potentiates effect of simvastatin on inhibition of mevalonate pathway in human endometrial stromal cells.Pharmacological Strategies to Retard Cardiovascular AgingCardiovascular effects of a novel SIRT1 activator, SRT2104, in otherwise healthy cigarette smokers.Resveratrol counters systemic lupus erythematosus-associated atherogenicity by normalizing cholesterol efflux.Comparison of effect of resveratrol and vanadium on diabetes related dyslipidemia and hyperglycemia in streptozotocin induced diabetic ratsResveratrol potentiates effects of simvastatin on inhibition of rat ovarian theca-interstitial cells steroidogenesis.Antiobesity and vasoprotective effects of resveratrol in apoE-deficient miceThe Search for Dietary Supplements to Elevate or Activate Circulating Paraoxonases.Anti-atherogenic effects of resveratrol.Effects of flavonoids and other polyphenols on inflammation.Resveratrol in cardiovascular disease: what is known from current research?Resveratrol in the prevention and treatment of coronary artery disease.A Review of the Pharmacological Effects of the Dried Root of Polygonum cuspidatum (Hu Zhang) and Its Constituents.Resveratrol and endothelial nitric oxide.Resveratrol supplementation: Where are we now and where should we go?Antioxidant effects of resveratrol in the cardiovascular system.Self-emulsifying drug delivery systems as a tool to improve solubility and bioavailability of resveratrolResveratrol promotes degradation of the human bile acid transporter ASBT (SLC10A2).Role of resveratrol in the management of insulin resistance and related conditions: Mechanism of action.Increased plasma membrane cholesterol in cystic fibrosis cells correlates with CFTR genotype and depends on de novo cholesterol synthesis.Nobiletin attenuates VLDL overproduction, dyslipidemia, and atherosclerosis in mice with diet-induced insulin resistance.
P2860
Q24618313-A24E289B-38F0-4E09-8695-84F81483E0D3Q26778562-A0F64C6C-2D4B-422B-8532-384FFB0EB31AQ26800907-9A837E3C-6F0C-4594-8F96-6E12760E89D7Q26824686-41FD0A4E-40EF-464B-8859-1E3ADCF281BDQ28910228-8A461D7D-49A3-4364-9D60-74D2D09B2C93Q33573661-CE138688-D96D-40AE-9589-3B6995C5F949Q34041717-ED239C83-A6E3-4ABD-9C1E-8D415BED6459Q34113185-C56CD091-A4F0-4759-B4D6-E9E7B6B53DE0Q34431964-DBAEA467-2097-4A8C-996B-4699A5FFDC9DQ34531843-FEBF8292-97C6-4EDC-845D-379552DD4B72Q34624641-6D45BD81-6ACF-48AB-80AA-D58C87384B01Q35113534-E44AD9F0-D096-4A52-8B18-AB0BE51919B2Q35127516-0BFD0150-EA16-4AB5-ADAD-EC7FF00F3029Q35421401-4189581A-A62B-4D1A-8A14-3E15B026D628Q35872279-A838FB43-FAEB-4307-A557-7B69765CF6D9Q36099455-99654C7B-7964-4C8A-BFA4-1E9C6DA5256BQ36238935-06ED660D-685F-4FA4-A8DF-9779A746780DQ36364263-6AC5CB91-7D3B-4DA1-8094-110C4089A109Q36608631-42CF77E8-CF02-40B6-8C0D-CF64E9A9B169Q36663002-BA64B8BE-9AAC-4C8C-929E-690BF3509F5DQ36972415-58C3CA55-E3C5-42F6-95EC-81FFE66D3C00Q36974218-1EB7A6ED-DB07-44DA-B9C2-7D2145CA9FCBQ37197627-798FD2D5-37B7-4AB3-8E7F-3579133935F3Q37354724-D7F34C4A-ADB3-4F36-AD95-5DD17C27DF44Q37613474-011A3247-2AAD-49E4-BA48-F03FB55E62ADQ37653755-15BC7B23-F036-409D-8A49-36C0EDCAD44EQ37690989-05F438C2-682C-4CC5-B5DE-852E219ED6E8Q37756520-16D9AA66-DB6D-40CF-A349-8BF8032F1C45Q37856995-4148027B-B14F-4F6A-B092-0473CA2EDDB4Q37891880-E0BD12C7-A947-424F-856A-F5077B9C8026Q37922623-8000DCBF-D3E5-4332-A7D1-E9F67D604178Q38160221-D71A1853-F3DD-42B3-86BF-8EFF641A9559Q38258814-D1AE75C3-60C4-4A0B-8FA1-85DE8936B1A3Q38334249-9F767172-E479-434E-A790-175B2A54E1DFQ38802176-1B75EED2-7ACE-447D-9A25-432E81096AB4Q38918022-5DA3F6A9-2FE5-43A0-85ED-E6713C61E86AQ39026925-F6AEFCB6-478D-438E-9D5E-20E748B2C386Q39432694-56F5FBF7-C62E-4EDD-9A46-6F4CA8A56005Q39701971-16FD294E-0BEF-40D3-B14C-262F6E60665BQ42151368-DB210EBD-62B6-4C3F-8693-8E721AE66F52
P2860
Long-term effects of resveratrol supplementation on suppression of atherogenic lesion formation and cholesterol synthesis in apo E-deficient mice.
description
2008 nî lūn-bûn
@nan
2008 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Long-term effects of resveratr ...... hesis in apo E-deficient mice.
@ast
Long-term effects of resveratr ...... hesis in apo E-deficient mice.
@en
Long-term effects of resveratr ...... hesis in apo E-deficient mice.
@nl
type
label
Long-term effects of resveratr ...... hesis in apo E-deficient mice.
@ast
Long-term effects of resveratr ...... hesis in apo E-deficient mice.
@en
Long-term effects of resveratr ...... hesis in apo E-deficient mice.
@nl
prefLabel
Long-term effects of resveratr ...... hesis in apo E-deficient mice.
@ast
Long-term effects of resveratr ...... hesis in apo E-deficient mice.
@en
Long-term effects of resveratr ...... hesis in apo E-deficient mice.
@nl
P2093
P1476
Long-term effects of resveratr ...... thesis in apo E-deficient mice
@en
P2093
Eun-Young Kwon
Gyeong-Min Do
Hye-Jin Kim
Myung-Sook Choi
Seon-Min Jeon
Tae-Youl Ha
P356
10.1016/J.BBRC.2008.06.113
P407
P50
P577
2008-07-09T00:00:00Z